Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
414
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Rhythm Pharmaceuticals Inc. market cap is $8.25B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rhythm Pharmaceuticals Inc. 52 week high is $122.20 as of November 19, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rhythm Pharmaceuticals Inc. 52 week low is $74.50 as of November 19, 2026.
Rhythm Pharmaceuticals Inc. stock price today is $116.80.
Rhythm Pharmaceuticals Inc. stock price yesterday was $119.04.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Rhythm Pharmaceuticals Inc.'s P/E ratio is -40.87.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Rhythm Pharmaceuticals Inc. P/B ratio is 93.8002.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Rhythm Pharmaceuticals Inc. 50-day moving average is $97.63.